RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 84 filers reported holding RAPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,553,131 | +48.7% | 153,618 | +67.4% | 0.00% | +50.0% |
Q2 2023 | $1,716,417 | +0.1% | 91,787 | -1.8% | 0.00% | 0.0% |
Q1 2023 | $1,715,505 | -7.3% | 93,488 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $1,851,062 | -19.5% | 93,488 | -3.0% | 0.00% | -33.3% |
Q3 2022 | $2,299,000 | +30.8% | 96,333 | 0.0% | 0.00% | +50.0% |
Q2 2022 | $1,758,000 | -18.5% | 96,333 | -1.7% | 0.00% | 0.0% |
Q1 2022 | $2,156,000 | -45.9% | 98,045 | -9.7% | 0.00% | -33.3% |
Q4 2021 | $3,987,000 | +53.5% | 108,543 | +29.8% | 0.00% | 0.0% |
Q3 2021 | $2,597,000 | +8.8% | 83,640 | +7.5% | 0.00% | +50.0% |
Q2 2021 | $2,387,000 | +66.1% | 77,840 | +20.3% | 0.00% | 0.0% |
Q1 2021 | $1,437,000 | +19.0% | 64,719 | +5.8% | 0.00% | +100.0% |
Q4 2020 | $1,208,000 | -35.3% | 61,162 | +5.5% | 0.00% | -66.7% |
Q3 2020 | $1,867,000 | +140.3% | 57,970 | +116.5% | 0.00% | +200.0% |
Q2 2020 | $777,000 | +132.6% | 26,770 | +70.5% | 0.00% | 0.0% |
Q1 2020 | $334,000 | -6.2% | 15,698 | +21.8% | 0.00% | 0.0% |
Q4 2019 | $356,000 | – | 12,888 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Column Group LLC | 2,680,621 | $44,551,921 | 29.58% |
GREAT POINT PARTNERS LLC | 1,458,070 | $24,233,123 | 4.41% |
Euclidean Capital LLC | 1,315,798 | $21,868,562 | 2.39% |
Trustees of Columbia University in the City of New York | 73,383 | $1,219,625 | 2.24% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 805,828 | $13,392,861 | 1.54% |
Perceptive Advisors | 1,920,658 | $31,921,336 | 1.06% |
Deep Track Capital, LP | 1,500,000 | $24,930,000 | 0.96% |
Cheyne Capital Management (UK) LLP | 20,000 | $332,400 | 0.96% |
Alphabet Inc. | 540,270 | $8,979,287 | 0.58% |
BRAIDWELL LP | 1,082,512 | $17,991,349 | 0.57% |